Endo to Acquire Boca Pharmacal

The specialty pharmaceutical company, Endo Health Solutions, Qualitest subsidiary has agreed to acquire Boca Pharmacal, a specialty generics company, for $225 million.

Boca Pharmacal is a specialty generics company that focuses on niche areas, commercializing and developing products in categories that include controlled substances, semisolids, and solutions. The deal is expected to close before the end of 2013, subject to standard regulatory requirements.